Is Avenue Therapeutics, Inc. (ATXI) a Buy, Sell, or Hold?
OTC : ATXI
Avenue Therapeutics, Inc.
$0.26 USD
$0 (0.0%)
- Volume
- 54
- Average Volume
- 2.79K
- Market Capitalization
- $856.69K
- P/E Ratio
- -0.47
- Dividend Yield
- 0.00%
- Price Target
- $12.00
- Year High
- $0.97
- Year Low
- $0.15
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $1.90
NUMBER OF INSIDERS BUYING (LAST 12 MONTHS)
11
NUMBER OF INSIDERS SELLING (LAST 12 MONTHS)
2
AMOUNT OF INSIDER SELLING (LAST 12 MONTHS)
$84
ATXI Estimated and Actual Revenue by Quarter
Get MSFT Insider Trade Alerts
ATXI Insider Trading History
| Insider Name | Title | Date | Transaction | Cost | Filing Date |
|---|---|---|---|---|---|
| Fortress Biotech, Inc. | 10 percent owner | 2026-01-02 | A-Award | 0 | 2026-01-06 |
| Fortress Biotech, Inc. | 10 percent owner | 2025-03-31 | A-Award | 0 | 2025-04-02 |
| Fortress Biotech, Inc. | 10 percent owner | 2024-12-31 | 0 | 2025-01-03 | |
| Herskowitz Neil | director | 2024-12-02 | S-Sale | 2 | 2024-12-03 |
| KRANZLER JAY D | director | 2024-11-05 | S-Sale | 2.24 | 2024-11-07 |
| KRANZLER JAY D | director | 2024-09-30 | P-Purchase | 2.5 | 2024-10-01 |
| KRANZLER JAY D | director | 2024-09-27 | P-Purchase | 2.4 | 2024-10-01 |
| ROSENWALD LINDSAY A MD | director | 2024-09-23 | A-Award | 2.46 | 2024-09-25 |
| Herskowitz Neil | director | 2024-09-23 | A-Award | 2.46 | 2024-09-25 |
| Oltmans Curtis Gale | director | 2024-09-23 | A-Award | 2.46 | 2024-09-25 |
| MacLean Alexandra | director, officer: Chief Executive Officer | 2024-09-23 | A-Award | 0 | 2024-09-25 |
| KRANZLER JAY D | director | 2024-09-23 | A-Award | 2.46 | 2024-09-25 |
| Jin David | officer: Interim PFO and COO | 2024-09-23 | A-Award | 0 | 2024-09-25 |
| Charles Faith L. | director | 2024-09-23 | A-Award | 2.46 | 2024-09-25 |
| Fortress Biotech, Inc. | 10 percent owner | 2024-04-16 | A-Award | 0 | 2024-04-17 |
| Fortress Biotech, Inc. | 10 percent owner | 2024-01-02 | A-Award | 0 | 2024-01-03 |
| Davidow Robert L | 10 percent owner | 2023-12-11 | S-Sale | 0.14 | 2023-12-13 |
| Davidow Robert L | 10 percent owner | 2023-12-11 | S-Sale | 0.14 | 2023-12-13 |
| Davidow Robert L | 10 percent owner | 2023-12-11 | S-Sale | 0.14 | 2023-12-13 |
| Davidow Robert L | 10 percent owner | 2023-12-11 | S-Sale | 0.14 | 2023-12-13 |
| Davidow Robert L | 10 percent owner | 2023-12-11 | S-Sale | 0.14 | 2023-12-13 |
| Davidow Robert L | 10 percent owner | 2023-12-11 | S-Sale | 0.15 | 2023-12-13 |
| Davidow Robert L | 10 percent owner | 2023-10-31 | 0 | 2023-11-28 | |
| Davidow Robert L | 10 percent owner | 2023-10-31 | 0 | 2023-11-28 | |
| Davidow Robert L | 10 percent owner | 2023-10-31 | 0 | 2023-11-28 | |
| Davidow Robert L | 10 percent owner | 2023-10-31 | 0 | 2023-11-28 | |
| Davidow Robert L | 10 percent owner | 2023-10-31 | 0 | 2023-11-28 | |
| Davidow Robert L | 10 percent owner | 2023-10-31 | 0 | 2023-11-28 | |
| Davidow Robert L | 10 percent owner | 2023-10-31 | 0 | 2023-11-28 | |
| ROSENWALD LINDSAY A MD | director | 2023-09-08 | P-Purchase | 0.72 | 2023-09-12 |
| Fortress Biotech, Inc. | 10 percent owner | 2023-09-08 | P-Purchase | 0.72 | 2023-09-12 |
| Charles Faith L. | director | 2023-06-30 | A-Award | 1.14 | 2023-07-05 |
| Jin David | officer: Interim PFO and COO | 2023-06-30 | A-Award | 1.14 | 2023-07-05 |
| ROSENWALD LINDSAY A MD | director | 2023-06-30 | A-Award | 1.14 | 2023-07-05 |
| KRANZLER JAY D | director | 2023-06-30 | A-Award | 1.14 | 2023-07-05 |
| Oltmans Curtis Gale | director | 2023-06-30 | A-Award | 1.14 | 2023-07-05 |
| Herskowitz Neil | director | 2023-06-30 | A-Award | 1.14 | 2023-07-05 |
| MacLean Alexandra | director, officer: Chief Executive Officer | 2023-06-29 | A-Award | 1.14 | 2023-07-03 |
| Fortress Biotech, Inc. | 10 percent owner | 2023-03-31 | A-Award | 0 | 2023-04-04 |
| Fortress Biotech, Inc. | director | 2023-01-03 | A-Award | 0 | 2023-01-04 |
| Fortress Biotech, Inc. | director | 2022-12-31 | A-Award | 0 | 2023-01-04 |
| InvaGen Pharmaceuticals, Inc. | director | 2022-10-11 | S-Sale | 7.714 | 2022-10-13 |
| MacLean Alexandra | officer | 2022-08-01 | 0 | 2022-08-03 | |
| Jin David | officer | 2022-05-11 | 0 | 2022-05-25 | |
| Charles Faith L. | director: | 2022-05-16 | 0 | 2022-05-17 | |
| KRANZLER JAY D | director | 2021-12-17 | A-Award | 0 | 2021-12-21 |
| KRANZLER JAY D | director | 2021-12-17 | A-Award | 0 | 2021-12-21 |
| Herskowitz Neil | director | 2021-12-17 | A-Award | 0 | 2021-12-21 |
| Herskowitz Neil | director | 2021-12-17 | A-Award | 0 | 2021-12-21 |
| Oltmans Curtis Gale | director | 2021-12-17 | A-Award | 0 | 2021-12-21 |
| Oltmans Curtis Gale | director: | 2021-04-01 | 0 | 2021-12-21 | |
| Lu Lucy | director, officer: President, CEO | 2021-12-17 | A-Award | 0 | 2021-12-20 |
| Vazzano Joseph Walter | officer: Chief Financial Officer | 2021-12-17 | A-Award | 0 | 2021-12-20 |
| Vazzano Joseph Walter | officer: Chief Financial Officer | 2021-09-15 | S-Sale | 1.62 | 2021-09-15 |
| Herskowitz Neil | director | 2021-05-06 | P-Purchase | 3.99 | 2021-05-07 |
| Vazzano Joseph Walter | officer: Chief Financial Officer | 2020-08-20 | S-Sale | 12.13 | 2020-08-21 |
| KRANZLER JAY D | director | 2020-06-16 | A-Award | 0 | 2020-06-16 |
| Herskowitz Neil | director | 2020-06-16 | A-Award | 0 | 2020-06-16 |
| Vazzano Joseph Walter | officer: Chief Financial Officer | 2020-03-10 | P-Purchase | 7.94 | 2020-03-10 |
| Vazzano Joseph Walter | officer: Chief Financial Officer | 2020-03-09 | P-Purchase | 7.97 | 2020-03-10 |
| Vazzano Joseph Walter | officer: Chief Financial Officer | 2020-03-09 | P-Purchase | 7.99 | 2020-03-10 |
| Herskowitz Neil | director | 2020-02-27 | P-Purchase | 8.2 | 2020-03-02 |
| Herskowitz Neil | director | 2020-02-26 | P-Purchase | 8.73 | 2020-03-02 |
| Vazzano Joseph Walter | officer: Chief Financial Officer | 2020-02-25 | P-Purchase | 9.09 | 2020-02-25 |
| Herskowitz Neil | director | 2020-02-25 | P-Purchase | 9.31 | 2020-02-25 |
| Vazzano Joseph Walter | officer: Chief Financial Officer | 2020-02-12 | A-Award | 0 | 2020-02-13 |
| Lu Lucy | director, officer: President, CEO | 2020-02-12 | A-Award | 0 | 2020-02-13 |
| InvaGen Pharmaceuticals, Inc. | 2019-02-08 | 0 | 2019-12-31 | ||
| InvaGen Pharmaceuticals, Inc. | 2019-02-08 | 0 | 2019-12-31 | ||
| InvaGen Pharmaceuticals, Inc. | 2019-02-08 | 0 | 2019-12-31 | ||
| InvaGen Pharmaceuticals, Inc. | 2019-02-08 | 0 | 2019-12-31 | ||
| Ingram Elizabeth Garrett | director | 2019-09-12 | P-Purchase | 6.27 | 2019-09-16 |
| KRANZLER JAY D | director | 2019-08-27 | A-Award | 0 | 2019-08-28 |
| Herskowitz Neil | director | 2019-08-27 | A-Award | 0 | 2019-08-28 |
| Vazzano Joseph Walter | officer: Chief Financial Officer | 2019-08-08 | S-Sale | 5.62 | 2019-08-12 |
| Vazzano Joseph Walter | officer: Chief Financial Officer | 2019-08-09 | S-Sale | 5.56 | 2019-08-12 |
| Ingram Elizabeth Garrett | director: | 2019-08-01 | 0 | 2019-08-01 | |
| Herskowitz Neil | director | 2019-06-18 | P-Purchase | 5.83 | 2019-06-19 |
| Herskowitz Neil | director | 2019-06-17 | P-Purchase | 5.88 | 2019-06-19 |
| Vazzano Joseph Walter | officer: Chief Financial Officer | 2019-06-03 | A-Award | 0 | 2019-06-05 |
| Lu Lucy | director, officer: President, CEO | 2019-06-03 | A-Award | 0 | 2019-06-05 |
| Moore Thomas Gregory | director: | 2019-04-30 | 0 | 2019-04-30 | |
| Herskowitz Neil | director | 2019-04-15 | P-Purchase | 4.52 | 2019-04-15 |
| Herskowitz Neil | director | 2019-03-29 | P-Purchase | 5.11 | 2019-03-29 |
| Herskowitz Neil | director | 2019-03-28 | P-Purchase | 5.11 | 2019-03-29 |
| Herskowitz Neil | director | 2019-02-25 | P-Purchase | 5.46 | 2019-02-25 |
| Gogtay Jaideep Ashok | 2019-02-08 | 0 | 2019-02-15 | ||
| Saxena Nishant | 2019-02-08 | 0 | 2019-02-15 | ||
| Herskowitz Neil | director | 2019-02-05 | P-Purchase | 5.77 | 2019-02-06 |
| Herskowitz Neil | director | 2019-02-04 | P-Purchase | 5.91 | 2019-02-06 |
| Herskowitz Neil | director | 2019-01-30 | P-Purchase | 5.91 | 2019-02-01 |
| Herskowitz Neil | director | 2019-01-29 | P-Purchase | 5.91 | 2019-01-30 |
| Herskowitz Neil | director | 2019-01-28 | P-Purchase | 5.84 | 2019-01-30 |
| Paley Jeffrey | director | 2018-12-10 | P-Purchase | 4.76 | 2018-12-12 |
| Paley Jeffrey | director | 2018-12-03 | P-Purchase | 5.4754 | 2018-12-12 |
| Vazzano Joseph Walter | officer: VP Finance & Corp. Controller | 2018-08-07 | G-Gift | 0 | 2018-08-08 |
| Lu Lucy | director, officer: President, CEO | 2018-08-07 | G-Gift | 0 | 2018-08-08 |
| ROSENWALD LINDSAY A MD | director | 2018-08-07 | G-Gift | 0 | 2018-08-08 |
| Herskowitz Neil | director | 2018-08-07 | G-Gift | 0 | 2018-08-08 |
| KRANZLER JAY D | director | 2018-08-07 | G-Gift | 0 | 2018-08-08 |